Ziegler Capital Management, LLC Coherus Bio Sciences, Inc. Transaction History

Ziegler Capital Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 21, 2022	SELL	$5.86 - $13.23 $232,858 - $525,720	-39,737 Closed	0 $0
Q4 2021 Feb 09, 2022	SELL	$15.81 - $18.99 $222,636 - $267,417	-14,082 Reduced 26.17%	39,737 $634,000
Q3 2021 Oct 27, 2021	SELL	$12.68 - $17.79 $24,789 - $34,779	-1,955 Reduced 3.51%	53,819 $865,000
Q2 2021 Jul 21, 2021	SELL	$12.95 - $15.41 $23,245 - $27,660	-1,795 Reduced 3.12%	55,774 $771,000
Q1 2021 Apr 29, 2021	BUY	$14.42 - $21.39 $412,642 - $612,096	28,616 Added 98.84%	57,569 $841,000
Q4 2020 Feb 05, 2021	SELL	$16.56 - $18.94 $56,039 - $64,092	-3,384 Reduced 10.46%	28,953 $503,000
Q3 2020 Oct 21, 2020	SELL	$17.41 - $19.89 $524,737 - $599,484	-30,140 Reduced 48.24%	32,337 $593,000
Q2 2020 Jul 24, 2020	BUY	$14.43 - $19.16 $901,543 - $1.2 Million	62,477 New	62,477 $1.12 Million

132

77.3M

40.7K

50.1K

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $87.8M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

Get notified when there are updates to the investment portfolio of Ziegler Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Ziegler Capital Management, LLC with notifications on news.